Английская Википедия:IL Therapeutics
Шаблон:Infobox company IL Therapeutics Inc. was previously owned by Western Life Sciences Venture Fund LP ("Western Life Sciences") and in 2006 its shares were purchased by Pacgen Biopharmaceuticals Corporation ("Pacgen").[1][2]
History
Saskatchewan Research Council operates a bioprocessing laboratory which facilitated biomedical research. IL Therapeutics was developed from research first begun at the Western College of Veterinary Medicine.
Pharmaceuticals
Currently IL Therapeutics is working on a drug candidate, IL-8(3-73)K11R/G31P ("PAC-G31P") for relief of Acute Respiratory Distress Syndrome (ARDS).[1] The Saskatchewan Research council, SRC also assisted with the funding of this project through the Agriculture Development Fund - SRC Industry Venture Fund.[3] With the successful progression of G31P, the University of Saskatchewan Industry Liaison Office (ILO) decided to commercialize a commercialize this new drug treatment.[4] This research has been sponsored by a $3 million boost from the Western Life Sciences Venture Fund (WLS)[5]
See also
- Biotechnology
- List of biotechnology companies
- Innovation Place Research Park
- University of Saskatchewan
References
External links
- ILC Therapeutics Ltd
- University of Saskatchewan Research - Discovery @ U of S: May 24, 2006
- AgBiotech Bulletin
- Europe and GMOs: the dance continues In this issue:
- U of S News Releases: November 2004 Archives
- Untitles
- Western College of Veterinary Medicine
- Английская Википедия
- Biotechnology companies established in 2005
- Research institutes in Canada
- University of Saskatchewan
- Companies based in Saskatoon
- Pharmaceutical companies of Canada
- Biotechnology companies of Canada
- Biotechnology companies disestablished in 2006
- 2006 mergers and acquisitions
- Страницы, где используется шаблон "Навигационная таблица/Телепорт"
- Страницы с телепортом
- Википедия
- Статья из Википедии
- Статья из Английской Википедии
